Canntab Therapeutics Ltd said it has appointed Richard Goldstein, currently the company s chief financial officer (CFO), as its interim chief executive.
Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) said it has entered into a license, supply, and commercialization agreement with Kaleo Inc for the Canadian rights.
Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) said it has entered into a commercialization and supply agreement with Novartis Pharmaceuticals Canada Inc for the.
Canntab Therapeutics Ltd said it has appointed Richard Goldstein, currently the company s chief financial officer (CFO), as its interim chief executive.